QSP Modeling for Parkinson’s Disease: Solving the Synthetic Control Challenge in Clinical Trials

QSP modeling for Parkinson’s disease tackles optimized standard-of-care, placebo response, and missing biomarkers. See how Virtual Twin® controls help.

Beyond Compliance: What ICH M15 Means for the Future of Drug Development

How interactive value communication tools strengthen the value proposition in healthcare

The end of the national launch: why regional pharma market access now determines commercial success

Strategies for navigating loss of exclusivity (LOE) in pharma

How to Choose the Right LLM for Medical Writing

Certainty US 2026 recap: advancing model-informed drug development right from the start

Why ask your CRO to use Pinnacle 21 Enterprise?

Everything You Need to Know About CRFs in Clinical Trials

Best Practices for AI Prompt Engineering in Life Sciences